All Stories

  1. Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?

    Article • PLoS Pathogens, September 2022, PLOS

    Suresh Mahalingam

  2. Interleukin-17 contributes to Ross River virus-induced arthritis and myositis

    Article • PLoS Pathogens, February 2022, PLOS

    Suresh Mahalingam

  3. Decreased Virulence of Ross River Virus Harboring a Mutation in the First Cleavage Site of Nonstructural Polyprotein Is Caused by a Novel Mechanism Leading to Increased Production of Interferon-Inducing RNAs

    Article • mBio, August 2018, ASM Journals

    Suresh Mahalingam

  4. Chikungunya: vaccines and therapeutics

    Article • F1000Research, December 2017, Faculty of 1000, Ltd.

    Suresh Mahalingam

  5. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design

    Article • mBio, February 2017, ASM Journals

    Suresh Mahalingam

  6. Effects of an In-Frame Deletion of the6kGene Locus from the Genome of Ross River Virus

    Article • Journal of Virology, February 2016, ASM Journals

    Suresh Mahalingam, Associate Professor Brett A Lidbury

  7. Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease

    Article • Journal of Virology, May 2015, ASM Journals

    Suresh Mahalingam

  8. Dual Proinflammatory and Antiviral Properties of Pulmonary Eosinophils in Respiratory Syncytial Virus Vaccine-Enhanced Disease

    Article • Journal of Virology, November 2014, ASM Journals

    Suresh Mahalingam

  9. Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection

    Article • Journal of Virology, October 2014, ASM Journals

    Natalie A Sims, Suresh Mahalingam